“…For Ageladine-A (Fujita et al, 2003), this was done following a previously described method (Bickmeyer et al, 2008;Bickmeyer, 2012) in which the average values obtained for each of the treatments are expressed as a proportion of the control values, and by assuming that non-specialized cells under these control conditions would present a putative pH i of 7.3-7.4. In contrast, as BCECF fluorescence intensity at 490nm linearly increases between pH6.4 and 7.8 (Silver, 2003), BCECF results were converted to pH i by constructing a calibration curve using the nigericin technique (nigericin sodium salt, 5mg, N7143, Sigma-Aldrich, St Louis, MO, USA) described previously (Thomas et al, 1979).…”